Who
George A. Kegler
Director
Company insider
Files Form 4 as: Director, Enveric Biosciences; EVP & CFO, Interim, Mallinckrodt.
In numbers
- Trades disclosed
- 8
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 3 Jan 2019
- Last trade
- 1 Jun 2026
- Last filed
- 3 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jun 2026filed 3 Jun 2026 | ENVB Enveric BiosciencesBiotechnology | SEC FORM 4 Code A | —18,518 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | ENVB Enveric BiosciencesBiotechnology | SEC FORM 4 Code A | —18,518 at $0.00 | filing |
| 23 Dec 2025filed 30 Dec 2025 | ENVB Enveric BiosciencesBiotechnology | SEC FORM 4 Code A | —7,633 at $0.00 | filing |
| 9 Oct 2024filed 11 Oct 2024 | ENVB Enveric BiosciencesBiotechnology | SEC FORM 4 Code A | —47,733 at $0.00 | filing |
| 15 Feb 2021filed 17 Feb 2021 | ENVB Enveric BiosciencesBiotechnology | SEC FORM 4 Code A | —15,957 at $0.00 | filing |
| 9 Jan 2019filed 11 Jan 2019 | Mallinckrodt | SEC FORM 4 Code F | $1,56181 at $19.27 | filing |
| 4 Jan 2019filed 7 Jan 2019 | Mallinckrodt | SEC FORM 4 Code F | $1,68798 at $17.21 | filing |
| 3 Jan 2019filed 7 Jan 2019 | Mallinckrodt | SEC FORM 4 Code F | $2,437151 at $16.14 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.